Fig. 4From: Comparative efficacy of the Leucofeligen™ FeLV/RCP and Purevax™ RCP FeLV vaccines against infection with circulating feline CalicivirusClinical scores in the post-challenge phase. a: Median (IQR in brackets) of cumulative clinical scores for temperature, ulcers, ocular discharge, nasal discharge and general status, in each group. The black circle indicates the median of total cumulative scores recorded in each cat and the dashes the 1nd and 3rd quartiles. b: Median (IQR in brackets) of maximum scores observed for each sign. The 6 parameters assessed are represented (weight, temperature, ulcers, ocular discharge, nasal discharge and general status). The black circle indicates the median of total maximum scores recorded in each cat and the dashes the 1nd and 3rd quartiles. Statistically significant differences between groups were observed on the median of the total scores per cat and are annotated as in Fig. 1. Leucofeligen™ FeLV/RCP: n = 10; Purevax™ RCP FeLV: n = 10 and control: n = 9Back to article page